Loading...
XKRX
002760
Market cap43mUSD
Jul 28, Last price  
1,008.00KRW
1D
-0.10%
1Q
-11.97%
Jan 2017
-12.80%
Name

Bolak Co Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
1.27
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-0.16%
Rev. gr., 5y
5.67%
Revenues
47.60b
+1.77%
15,065,090,00018,659,886,00021,537,274,00023,189,664,00025,276,708,42031,403,500,82030,749,425,97031,151,277,34031,066,713,87035,708,601,32033,456,068,71033,763,266,62036,123,805,07038,292,697,00039,763,912,51048,434,715,67046,773,797,12047,600,285,850
Net income
-1.51b
L
-1,240,786,000193,915,000463,709,000656,606,000124,894,3701,921,287,990719,938,8302,079,543,210-172,455,6403,032,427,1901,238,718,5301,105,109,210648,533,670394,508,5001,694,987,5503,069,106,050857,813,413-1,509,722,950
CFO
904m
-40.63%
397,219,000-423,441,000392,329,0001,599,640,000784,278,2403,794,667,9901,992,366,6203,630,424,3603,184,487,1405,452,115,150705,777,3103,377,011,7501,463,212,9302,029,892,9801,177,596,8102,548,454,1401,522,906,470904,073,570
Dividend
Dec 27, 20235 KRW/sh

Profile

Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, and dairy flavoring products; active pharmaceutical ingredients, such as dry extract powders, viscous extracts, fluid extracts, tinctures, natural paclitaxel, docetaxel trihydrates, and Ca-CMC; health subsidiary foods, including green tea extracts, soy isoflavones, and ginseng extracts; and food coloring products. It also provides gum base products; cosmetic ingredients; fragrances for use in perfumes, cosmetics, hair products, daily supplies, toilet soaps, candles, and industrial products; and other products, such as sweeteners, surfactants, whitening agents, preservatives, antioxidants, abrasives, thickening agents, thickeners, caffeine, and baking powder. Bolak Company Limited was founded in 1959 and is headquartered in Hwaseong-si, South Korea.
URL
http://www.bolak.co.kr/
IPO date
Nov 30, 1989
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
47,600,286
1.77%
46,773,797
-3.43%
48,434,716
21.81%
Cost of revenue
45,318,101
43,411,598
42,272,458
Unusual Expense (Income)
NOPBT
2,282,185
3,362,199
6,162,258
NOPBT Margin
4.79%
7.19%
12.72%
Operating Taxes
(43,557)
(134,048)
319,944
Tax Rate
5.19%
NOPAT
2,325,742
3,496,247
5,842,314
Net income
(1,509,723)
-276.00%
857,813
-72.05%
3,069,106
81.07%
Dividends
(299,500)
(419,300)
(299,500)
Dividend yield
0.46%
0.53%
0.31%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
36,102
79,984
3,078,940
Long-term debt
2,044,202
2,120,484
247,009
Deferred revenue
Other long-term liabilities
2,480,746
83,297
65,107
Net debt
(1,546,360)
(1,095,007)
(4,864,481)
Cash flow
Cash from operating activities
904,074
1,522,906
2,548,454
CAPEX
(267,799)
(569,030)
(649,749)
Cash from investing activities
(184,522)
108,573
(915,374)
Cash from financing activities
(388,362)
(1,498,240)
(382,999)
FCF
2,375,816
3,933,145
4,744,501
Balance
Cash
3,626,665
3,295,475
3,162,236
Long term investments
5,028,194
Excess cash
1,246,650
956,785
5,768,694
Stockholders' equity
36,202,895
38,346,508
38,350,517
Invested Capital
49,961,624
50,058,449
45,544,566
ROIC
4.65%
7.31%
12.99%
ROCE
4.27%
6.30%
11.45%
EV
Common stock shares outstanding
59,424
59,900
59,900
Price
1,086.00
-17.04%
1,309.00
-18.70%
1,610.00
-18.69%
Market cap
64,534,195
-17.70%
78,409,100
-18.70%
96,439,000
-18.69%
EV
62,987,835
77,314,093
91,574,519
EBITDA
4,047,954
5,253,064
8,144,202
EV/EBITDA
15.56
14.72
11.24
Interest
97,294
89,692
67,512
Interest/NOPBT
4.26%
2.67%
1.10%